A week after Beau Friesen’s birth, his parents noticed signs of a medical issue, but two years later, a diagnosis remains elusive. Seeking answers, the Grunthal, Manitoba, couple is traveling to Florida. Initially, infant Beau exhibited vomiting and a swollen abdomen, prompting a visit to their family doctor and eventual referral to the Children’s Hospital in Winnipeg.
Subsequently, the Friesens embarked on a challenging journey, shuttling to various specialists multiple times a week to address Beau’s perplexing symptoms in gastroenterology, orthopedics, neurology, and genetics. Despite exhaustive consultations, the root cause remained unidentified, leaving the family in a state of uncertainty.
Beau, now two, displays reduced muscle tone, causing delays in crawling and walking, fatigue, and developmental delays affecting his motor skills and speech. To unravel this medical mystery, the Friesens’ genetic counselor suggested consulting Dr. Parul Jayakar at the Undiagnosed Disease Clinic at Nicklaus Children’s Hospital in Florida.
The Friesens anticipate that Dr. Jayakar’s expertise in genome sequencing will provide crucial insights for Beau’s condition. Genome sequencing involves comparing a patient’s DNA with that of a healthy individual to pinpoint genetic variations, aiding in early diagnosis of rare diseases.
Apart from seeking answers for Beau’s health, the Friesens aim to contribute to scientific research and access support programs through a potential diagnosis. Despite receiving support from their network, the uncertainty surrounding Beau’s condition makes the journey a solitary one for the family.
Dr. Jayakar, who honed her skills in genetics in Winnipeg before moving to Florida, emphasizes the importance of genetic testing in diagnosing complex conditions. She conducts thorough assessments, analyzing patients’ genetic makeup to formulate personalized treatment plans, including genetic therapy.
While genome sequencing is not currently available in Manitoba, the Friesens are funding their trip to Florida for consultations and testing. The costs of genomic analysis are covered by the clinic, with results expected within four to eight weeks post-visit. To finance the trip, the Friesens have initiated a GoFundMe campaign, as Manitoba Health does not cover such expenses.
Dr. Patrick Frosk, Manitoba’s genetics lead, lauds the state’s adoption of exome monogenic sequencing but advocates for more advanced full genome sequencing. He stresses the need for accurate interpretation of genetic data and the evolving nature of genetic testing, emphasizing early diagnosis for effective treatment.
In conclusion, the Friesens remain hopeful that their journey to Florida will provide the answers needed to improve Beau’s quality of life and contribute to medical advancements in genetic testing and therapy.